Pembrolizumab Monotherapy Effective for Rare Melanoma
Pembrolizumab led to a dramatic overall response rate among patients with unresectable desmoplastic melanoma.
Source: medscape.com
Stay updated with breaking news from Zeynep Aroglu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pembrolizumab led to a dramatic overall response rate among patients with unresectable desmoplastic melanoma.